D M Wilson

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Growth hormone and hypophosphatemic rickets
    D M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, CA 94305 5208, USA
    J Pediatr Endocrinol Metab 13:993-8. 2000
  2. ncbi A brief review of the use and utility of growth hormone stimulation testing in the NCGS: do we need to do provocative GH testing?
    Darrell M Wilson
    Pediatric Endocrinology and Diabetes, Stanford University, S 032 Medical Center, Stanford, CA 94305 5208, USA
    Growth Horm IGF Res 15:S21-5. 2005
  3. ncbi Assessing weight-related biochemical cardiovascular risk factors in African-American girls
    Darrell M Wilson
    Stanford University School of Medicine, Stanford, California, USA
    Obes Res 12:73S-83S. 2004
  4. ncbi Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University and the Lucile Packard Children s Hospital at Stanford, G 313 Medical Center, Stanford, CA 94305 5208, USA
    Arch Pediatr Adolesc Med 164:116-23. 2010
  5. ncbi Progress in the treatment of childhood diabetes mellitus and obesity
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, CA 94305 5208, USA
    J Pediatr Endocrinol Metab 15:745-9. 2002
  6. ncbi A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305 5208, USA
    Diabetes Care 28:15-9. 2005
  7. ncbi Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going?
    Darrell M Wilson
    Stanford University, Stanford, California, USA
    Diabetes Technol Ther 7:788-91. 2005
  8. ncbi Regular monitoring of bone age is not useful in children treated with growth hormone
    D M Wilson
    Department of Pediatrics, Stanford University, Stanford, Cali fornia 94305 5208, USA
    Pediatrics 104:1036-9. 1999
  9. ncbi Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristics
    Thomas N Robinson
    Department of Pediatrics and Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA
    Contemp Clin Trials 29:56-69. 2008
  10. ncbi The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age
    Laura M Gandrud
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
    Diabetes Technol Ther 9:307-16. 2007

Research Grants

  1. Type 1 Diabetes TrialNet at Stanford
    Darrell Wilson; Fiscal Year: 2007

Detail Information

Publications44

  1. ncbi Growth hormone and hypophosphatemic rickets
    D M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, CA 94305 5208, USA
    J Pediatr Endocrinol Metab 13:993-8. 2000
    ..Reported increases in phosphate concentrations following GH in XLHR are of uncertain clinical benefit. While GH appears to be safe in XLHR, long-term benefits remain unclear...
  2. ncbi A brief review of the use and utility of growth hormone stimulation testing in the NCGS: do we need to do provocative GH testing?
    Darrell M Wilson
    Pediatric Endocrinology and Diabetes, Stanford University, S 032 Medical Center, Stanford, CA 94305 5208, USA
    Growth Horm IGF Res 15:S21-5. 2005
    ....
  3. ncbi Assessing weight-related biochemical cardiovascular risk factors in African-American girls
    Darrell M Wilson
    Stanford University School of Medicine, Stanford, California, USA
    Obes Res 12:73S-83S. 2004
    ..We examined the feasibility of obtaining fasting blood samples and report correlates of these biochemical markers in an understudied population sample...
  4. ncbi Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University and the Lucile Packard Children s Hospital at Stanford, G 313 Medical Center, Stanford, CA 94305 5208, USA
    Arch Pediatr Adolesc Med 164:116-23. 2010
    ..Metformin has been proffered as a therapy for adolescent obesity, although long-term controlled studies have not been reported...
  5. ncbi Progress in the treatment of childhood diabetes mellitus and obesity
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, CA 94305 5208, USA
    J Pediatr Endocrinol Metab 15:745-9. 2002
    ..Obesity, an increasing problem in pediatric patients, was also addressed...
  6. ncbi A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes
    Darrell M Wilson
    Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305 5208, USA
    Diabetes Care 28:15-9. 2005
    ....
  7. ncbi Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going?
    Darrell M Wilson
    Stanford University, Stanford, California, USA
    Diabetes Technol Ther 7:788-91. 2005
  8. ncbi Regular monitoring of bone age is not useful in children treated with growth hormone
    D M Wilson
    Department of Pediatrics, Stanford University, Stanford, Cali fornia 94305 5208, USA
    Pediatrics 104:1036-9. 1999
    ..Routine monitoring of bone age during GH therapy is unnecessary. Bayley and Pinneau, bone age determination, Greulich and Pyle, predicted height, radiography, Tanner and Whitehouse...
  9. ncbi Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristics
    Thomas N Robinson
    Department of Pediatrics and Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA
    Contemp Clin Trials 29:56-69. 2008
    ....
  10. ncbi The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age
    Laura M Gandrud
    Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA
    Diabetes Technol Ther 9:307-16. 2007
    ..Our goal was to assess the incidence of hypoglycemia as well as postprandial glycemic patterns in this age group utilizing continuous glucose monitoring...
  11. ncbi Intensive diabetes management in pediatric patients
    B Buckingham
    Department of Pediatric Endocrinology, Stanford University, Stanford Medical Center, Room S 302, Stanford, CA 94305 5208, USA
    Curr Diab Rep 1:11-8. 2001
    ..This article provides a brief overview of the rationale for implementing intensive diabetes management in pediatric patients, and practical guidelines for implementation...
  12. ncbi Semi-automated entry of clinical temporal-abstraction knowledge
    Y Shahar
    Stanford Medical Informatics, Stanford University, California 94305 5479, USA
    J Am Med Inform Assoc 6:494-511. 1999
    ..The authors discuss the usability of an automated tool that supports entry, by clinical experts, of the knowledge necessary for forming high-level concepts and patterns from raw time-oriented clinical data...
  13. ncbi Prospective study of risk factors for the initiation of cigarette smoking
    J D Killen
    Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    J Consult Clin Psychol 65:1011-6. 1997
    ..The data suggest that future research is needed to examine potential gender differences that may have implications for the next generation of smoking-prevention programs...
  14. ncbi Weight concerns influence the development of eating disorders: a 4-year prospective study
    J D Killen
    Department of Medicine, Stanford University School of Medicine, Palo Alto, California 94304, USA
    J Consult Clin Psychol 64:936-40. 1996
    ..This finding is consistent with both theoretical and clinical perspectives and may represent a useful step toward the establishment of a rational basis for the choice of a prevention intervention target...
  15. ncbi Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty
    Angela Badaru
    Division of Pediatric Endocrinology and Diabetes, Stanford University, Stanford, California 94305, USA
    J Clin Endocrinol Metab 91:1862-7. 2006
    ..Whether various DL doses lead to long-term therapeutic differences remains to be determined...
  16. ncbi Definition of metabolic syndrome in preadolescent girls
    Carolyn H Chi
    Department of Pediatrics, Stanford University and the Lucile Packard Children s Hospital at Stanford, Stanford Prevention Research Center, Stanford, California 94305 5208, USA
    J Pediatr 148:788-792. 2006
    ..To compare and contrast proposed definitions of metabolic syndrome in pediatrics, and to determine prevalence of metabolic syndrome in preadolescent females when applying different criteria...
  17. ncbi Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit
    Kupper A Wintergerst
    Department of Pediatrics, Pediatric Endocrinology and Diabetes, Stanford University, S 302 Medical Center, Stanford, California 94305 5208, USA
    Pediatrics 118:173-9. 2006
    ..We evaluated retrospectively plasma glucose levels and the degree of hypoglycemia, hyperglycemia, and glucose variability in a PICU and then assessed their association with hospital length of stay and mortality rates...
  18. ncbi Real-time continuous glucose monitoring
    Bruce Buckingham
    Department of Pediatric Endocrinology, Stanford Medical Center, Stanford, California 94305 5208, USA
    Curr Opin Endocrinol Diabetes Obes 14:288-95. 2007
    ..To summarize the current literature on real-time continuous glucose monitors, focusing on devices that have been approved or are pending approval...
  19. ncbi Duration of nocturnal hypoglycemia before seizures
    Bruce Buckingham
    Lucile Packard Children s Hospital at Stanford, Pediatric Endocrinology, Stanford, California, USA
    Diabetes Care 31:2110-2. 2008
    ..Despite a high incidence of nocturnal hypoglycemia documented by the use of continuous glucose monitoring (CGM), there are no reports in the literature of nocturnal hypoglycemic seizures while a patient is wearing a CGM device...
  20. ncbi Real-Time hypoglycemia prediction suite using continuous glucose monitoring: a safety net for the artificial pancreas
    Eyal Dassau
    Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, California, USA
    Diabetes Care 33:1249-54. 2010
    ..This approach can provide a solution to the problem of nocturnal hypoglycemia, a major concern of patients with diabetes...
  21. ncbi Insulin pumps in young children
    Kimberly Fuld
    Division of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305 5208, USA
    Diabetes Technol Ther 12:S67-71. 2010
    ..There are advantages and disadvantages related to both CSII and MDI treatments, and ultimately the decision to use CSII should be individualized for each patient and family with the guidance of their diabetes team...
  22. ncbi A randomized controlled trial of culturally tailored dance and reducing screen time to prevent weight gain in low-income African American girls: Stanford GEMS
    Thomas N Robinson
    Division of General Pediatrics and Stanford Prevention Research Center, Stanford University School of Medicine, 1070 Arastradero Road, Palo Alto, CA 94304, USA
    Arch Pediatr Adolesc Med 164:995-1004. 2010
    ..To test a 2-year community- and family-based obesity prevention program for low-income African American girls: Stanford GEMS (Girls' health Enrichment Multi-site Studies)...
  23. ncbi Response to nocturnal alarms using a real-time glucose sensor
    Bruce Buckingham
    Stanford University School of Medicine, Stanford, California 94305 5208, USA
    Diabetes Technol Ther 7:440-7. 2005
    ..The objective of this study was to determine how subjects responded to alarms for hypo- and hyperglycemia while they were sleeping...
  24. ncbi Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy
    Suruchi Bhatia
    Department of Pediatrics, Division of Endocrinology and Diabetes, Stanford University, Stanford, California 94305 5208, USA
    Pediatrics 109:E30. 2002
    ..To find the time of the serum gonadotropin peak after depot leuprolide injection in children and to show that depot leuprolide therapy can be monitored by measuring serum luteinizing hormone (LH) immediately after injections...
  25. ncbi Dance and reducing television viewing to prevent weight gain in African-American girls: the Stanford GEMS pilot study
    Thomas N Robinson
    Division of General Pediatrics, Department of Pediatrics, The Stanford Center for Research in Disease Prevention, Palo Alto, CA 94304, USA
    Ethn Dis 13:S65-77. 2003
    ..To test the feasibility, acceptability, and potential efficacy of after-school dance classes and a family-based intervention to reduce television viewing, thereby reducing weight gain, among African-American girls...
  26. ncbi Alternatives to growth hormone stimulation testing in children
    Angela Badaru
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, S 302, Stanford, CA 94305 5208, USA
    Trends Endocrinol Metab 15:252-8. 2004
    ..Here, we examine the alternatives to the GHST that are currently available and literature that supports their use. We believe that these alternative methods should replace the GHST...
  27. ncbi Is growth hormone stimulation testing in children still appropriate?
    Laura M Gandrud
    Division of Pediatric Endocrinology and Diabetes, Stanford University Medical Center, S 302, Stanford University, Stanford, CA 94305 5208, USA
    Growth Horm IGF Res 14:185-94. 2004
    ..We recommend that GH stimulation tests no longer routinely be used for the diagnosis of GHD in children...
  28. ncbi Use of the Cygnus GlucoWatch biographer at a diabetes camp
    Laura M Gandrud
    Stanford University School of Medicine, Stanford, California 94305 5208, USA
    Pediatrics 113:108-11. 2004
    ..Detection and prevention of nocturnal hypoglycemia is a major medical concern at diabetes camps...
  29. ncbi Catch-up growth in severe juvenile hypothyroidism: treatment with a GnRH analog
    Louisa Teng
    Pediatric Endocrinology and Diabetes, Stanford Medical Center, Stanford, CA 94305-5208, USA
    J Pediatr Endocrinol Metab 17:345-54. 2004
    ..Changes in BMI Z score were similar for both groups. Our study suggests that the addition of GnRHa to LT4 may improve interval growth without imposing a risk of obesity in children with longstanding severe hypothyroidism...
  30. ncbi Prorenin and vascular complications of diabetes
    J A Luetscher
    Department of Medicine, Stanford University School of Medicine, California
    Am J Hypertens 2:382-6. 1989
    ..In the majority of our patients with type 2 diabetes who are hypertensive or are taking a medication that affects plasma prorenin, microalbuminuria may prove to be a more reliable warning of vascular complications...
  31. ncbi Bone mineral density in pediatric transplant recipients
    Mark W Daniels
    Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA
    Transplantation 76:673-8. 2003
    ..Low bone density and the occurrence of vertebral fractures indicate that cardiac, renal, and bone marrow transplantation in children is associated with reduced bone health...
  32. ncbi Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm
    Kupper A Wintergerst
    Pediatric Endocrinology, Kosair Children s Hospital, University of Louisville, Louisville, Kentucky 40202, USA
    Diabetes Technol Ther 9:211-22. 2007
    ..We have evaluated the use of a discrete proportional-integral-derivative (PID) algorithm to control hyperglycemia in pediatric ICU (PICU) patients both with and without diabetes...
  33. ncbi Limitations of statistical measures of error in assessing the accuracy of continuous glucose sensors
    Craig Kollman
    The Jaeb Center for Health Research, Tampa, Florida 33647, USA
    Diabetes Technol Ther 7:665-72; discussion 673-4. 2005
    ..Various statistical methods are commonly used to assess the accuracy of near-continuous glucose sensors. The performance and reliability of these methods have not been well described...
  34. ncbi JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods
    William V Tamborlane
    Diabetes Technol Ther 10:310-21. 2008
    ..RESULTS: Recruitment for the study was completed on December 15, 2007. CONCLUSION: Results of this clinical trial should help establish whether or not current RT-CGM devices are beneficial to patients with T1D...
  35. ncbi Early sexual maturation, body composition, and obesity in African-American girls
    John H Himes
    Division of Epidemiology, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454, USA
    Obes Res 12:64S-72S. 2004
    ..To describe associations between sexual maturation and body composition in a sample of African-American girls who were participants in phase 1 pilot interventions of the Girls Health Enrichment Multisite Studies...
  36. ncbi Continuous glucose monitoring and intensive treatment of type 1 diabetes
    William V Tamborlane
    N Engl J Med 359:1464-76. 2008
    ..Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. (ClinicalTrials.gov number, NCT00406133.)..
  37. ncbi Initiation of insulin glargine in children and adolescents with type 1 diabetes
    Chin Yao Tan
    Faculty of Medicine, University of Melbourne, Parkville, Victoria, Australia
    Pediatr Diabetes 5:80-6. 2004
    ..CONCLUSION: This retrospective study suggests that glargine is at least as effective as other long-acting insulins but that care must be taken during the conversion process to avoid hypoglycemia...
  38. ncbi Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator)
    Bruce Buckingham
    Pediatr Diabetes 9:142-7. 2008
    ..CONCLUSIONS: These results show the feasibility of implementing the DATA when real-time continuous glucose monitoring is initiated and support its use in future clinical trials of real-time continuous glucose monitoring...
  39. ncbi Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors
    Darrell M Wilson
    Diabetes Care 31:381-5. 2008
    ..There is, however, substantial variability in individual mean glucose concentrations for a given A1C. Transforming reliable A1C values into calculated mean glucose values would, when applied to an individual, introduce substantial error...
  40. ncbi Evaluation of factors affecting CGMS calibration
    Bruce A Buckingham
    DirecNet Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, FL 33647, USA
    Diabetes Technol Ther 8:318-25. 2006
    ..The optimal number/timing of calibrations entered into the CGMS (Medtronic MiniMed, Northridge, CA) continuous glucose monitoring system have not been previously described...
  41. ncbi The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes
    Darrell M Wilson
    DirecNet Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Dr, Suite 350, Tampa, FL 33647, USA
    Diabetes Care 30:59-64. 2007
    ..To evaluate the accuracy and precision of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes...
  42. ncbi The accuracy of the Guardian RT continuous glucose monitor in children with type 1 diabetes
    Michael Tansey
    Diabetes Technol Ther 10:266-72. 2008
    ..The Guardian RT has an accuracy similar to that of other available continuous glucose monitors and can give important and useful clinical information...
  43. ncbi Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study
    William V Tamborlane
    Jaeb Center for Health Research, Tampa, FL 33647, USA
    Pediatr Diabetes 6:13-6. 2005
    ..The DCA 2000 + Analyzer (Bayer Inc., Tarrytown, NY, USA), which uses an immunoassay, is a very popular device for measuring HbA1c levels in pediatric diabetes practices...
  44. ncbi Microvascular abnormalities in pediatric diabetic patients
    Anthony T W Cheung
    Department of Medical Pathology, University of California, Davis School of Medicine, 95616, USA
    Microvasc Res 63:252-8. 2002
    ..This study confirms that CAIM may represent the availability of a useful real-time technology to study conjunctival microvascular abnormalities in vascular diseases in juvenile as well as adult patients...

Research Grants1

  1. Type 1 Diabetes TrialNet at Stanford
    Darrell Wilson; Fiscal Year: 2007
    ..We propose to initiate Phase 1 safety studies followed by Phase 2 efficacy studies using DNA vaccination with insulin B:9-23. ..